期刊档案 · 医学-病理学
Korean Journal of Pathology
ISSN 1738-1843 · SOUTH KOREA · Bimonthly · 创刊 2004
Korean Journal of Pathology 完全开放获取,APC 约 175 美元,投稿社区反馈审稿6–12 周,录用比例容易(社区反馈),2025 年发文 50 篇,期刊官网显示已更换出版社。
期刊官网显示已更换出版社:JPTM provides the electronic backup and preservation of access to the journal content in the event the journal is no longer published by archiving in PubMed Central. 原文 ↗出版商官网 ·
研究范围
研究范围与定位
Korean Journal of Pathology。按 OpenAlex 近年发文统计,该刊主要发表 Metastasis and carcinoma case studies、Sarcoma Diagnosis and Treatment、Thyroid Cancer Diagnosis and Treatment 等主题的论文,这 3 个主题约占 22.2%,主导子领域为 Pulmonary and Respiratory Medicine。(根据 OpenAlex 主题统计与中科院分区数据生成)
The Journal of Pathology and Translational Medicine is an open venue for the rapid publication of major achievements in various fields of pathology, cytopathology, and biomedical and translational research. The Journal aims to share new insights into the molecular and cellular mechanisms of human diseases and to report major advances in both experimental and clinical medicine, with a particular emphasis on translational research. The investigations of human cells and tissues using high-dimensional biology techniques such as genomics and proteomics will be given a high priority. Articles on stem cell biology are also welcome. The manuscript types include original articles, review articles, case studies, and letters to the editor.
摘自期刊官网 Aims & Scope
研究方向(LetPub):医学-病理学
编委会国家分布:中国大陆 2 位(约 4%);主要国家 韩国 28、日本 5、美国 4、中国 2、中国香港 2(共 52 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Metastasis and carcinoma case studiesMedicine8.4%
- Sarcoma Diagnosis and TreatmentMedicine7.8%
- Thyroid Cancer Diagnosis and TreatmentMedicine6.1%
- Lymphoma Diagnosis and TreatmentMedicine5.8%
- Breast Lesions and CarcinomasMedicine5.4%
- Thyroid and Parathyroid SurgeryMedicine4.7%
- Gastric Cancer Management and OutcomesMedicine4.4%
- Breast Cancer Treatment StudiesBiochemistry, Genetics and Molecular Biology4.2%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
DOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore(出版商公布)
- 75出版商官网 ·
- h-index
- 51OpenAlex ·
- i10-index
- 507OpenAlex ·
- 两年平均被引
- 2.44OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
发文规模
- 年文章数
- 99LetPub ·
逐年发文量 OpenAlex 统计 · 累计 1,837 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 54 | 54 | 1,382 |
| 2025 | 50 | 50 | 1,734 |
| 2024 | 46 | 46 | 1,783 |
| 2023 | 40 | 40 | 1,958 |
| 2022 | 44 | 44 | 1,761 |
| 2021 | 56 | 56 | 1,685 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
- 平均审稿速度(社区反馈)
- 较慢,6-12周LetPub ·
- 平均录用比例(社区反馈)
- 容易LetPub ·
- 评审方式
- 单盲同行评审出版商官网
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,通常向作者收取文章处理费(APC)。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| OpenAlex | USD 175 | — | — | |
| 出版商官网 | 有,金额未公布 | — | — |
其他费用与减免(作者指南)
- 其他费用
- 无其他费用
- 投稿费
- 无投稿费
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点4 项,摘自作者指南
- 摘要
- ≤ 250 词
- 关键词
- 3–5 个
- 参考文献格式
- Vancouver 格式
- 投稿信(Cover letter)
- 必须提供
接收的文章类型9 种
- case studiesThe manuscript types include original articles, review articles, case studies, and letters to the editor.未说明篇幅
- hypothesis1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…未说明篇幅
- letters to the editorThe manuscript types include original articles, review articles, case studies, and letters to the editor.未说明篇幅
- letters to the editorsThe Editors welcome brief letters (not more than two A4 pages in length) commenting on articles appearing in recent issues, on general interests for pathologist…未说明篇幅
- original article1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…未说明篇幅
- original articles1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…未说明篇幅
- review1. Original articles The arrangement of an original article is as follows: Title Page, Abstract and Keywords, Introduction, Materials and Methods, Results, Disc…未说明篇幅
- review articlesThe manuscript types include original articles, review articles, case studies, and letters to the editor.未说明篇幅
- reviews and editorialsReviews and Editorials are normally by invitation only. Unsolicited articles are rarely considered, but if you wish to enquire further about the suitability of …未说明篇幅
官网政策摘录作者资格、利益冲突、出版伦理、许可与版权、同行评审、查重、试验注册 / 报告规范
- 作者资格 7) Author Contributions
该期刊采用CRediT标准描述作者贡献,所有作者的贡献必须按照CRediT作者角色分类法填写,每个类别填写贡献作者的姓名首字母缩写,同一类别有多位作者时用逗号分隔,无贡献的类别可留空。 模型中文摘要
JPTM participates in the CRediT standard for author contributions (https://casrai.org/credit/). The contributions of all authors must be described using the CRediT Taxonomy of author roles. For each of the categories below, please enter the initials of the authors who contributed in that category. If listing more than one author in a category, separate each set of initials with a coma. If no one c…
原文 ↗出版商官网 ·- 利益冲突 3) Disclosure of Potential Conflicts of Interest
作者须在参考文献列表之前的单独章节中声明所有可能直接或潜在影响该工作的关系或利益,作者对虚假声明或未遵守伦理指南负责,所有作者均有责任披露可能影响论文内容的利益冲突。 模型中文摘要
A statement disclosing all relationships or interests that could have direct or potential influence on the work should be included in a separate section before the reference list. The authors will be held responsible for any false statements or failure to follow the ethical guidelines. Each author should have participated in the research and/or article preparation. All authors are responsible for …
原文 ↗出版商官网 ·- 出版伦理 1) Ethical Approval
所有涉及人类受试者的研究应遵循1964年《赫尔辛基宣言》,作者须提供经相应机构审查委员会(IRB)和/或国家研究伦理委员会批准的声明(含批准号和日期),并在材料与方法部分末尾附上规定的批准声明。 模型中文摘要
All studies on human subjects should follow the World Medical Association Declaration of Helsinki (1964) and the authors should provide an affirmation that the studies have been approved by the appropriate institutional review board (IRB) and/or national research ethics committee with relevant reference numbers and dates. The following statement should be included in the text at the end of the Mat…
原文 ↗出版商官网 ·- 许可与版权 COPYRIGHT, LICENSING, AND ARCHIVING POLICY
所有已发表论文永久归韩国病理学会和韩国细胞病理学会所有,版权亦归这两个学会,商业使用材料须经其许可,每位作者应在出版过程中同意版权转让并通过在线投稿系统签署版权转让协议。 模型中文摘要
All published papers become the permanent property of the Korean Society of Pathologists and the Korean Society for Cytopathology. Copyrights of all published materials are owned by the Korean Society of Pathologists and the Korean Society for Cytopathology. Permission must be obtained from the Korean Society of Pathologists and the Korean Society for Cytopathology for any commercial use of materi…
原文 ↗出版商官网 ·- 同行评审 REVIEW PROCESS
所有论文(包括编辑约稿)均须同行评审,由至少2位外部专家和编辑审阅,投稿后2周内发出初步编辑决定,采用单盲评审(审稿人知晓作者身份),最终决定由编辑负责,文章在最终接受后2个月内发表。 模型中文摘要
1. Peer-Review Process All papers, including those invited by the Editor, are subject to peer review. Manuscripts are reviewed by at least 2 external experts and editors. Received manuscripts will be peer-reviewed and a primary editorial decision will be sent to the authors within 2 weeks after submission. The Editor is responsible for the final decision whether the manuscript is accepted or rejec…
原文 ↗出版商官网 ·- 查重 4) Redundant Publication and Plagiarism
重复发表指未注明原始来源而多次报告(发表或试图发表)实质相同的工作,其特征包括至少一位作者共同、研究人群相同或重叠、方法基本相同、结果及其解释几乎无差异。 模型中文摘要
Redundant publication is defined as "reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s)". Characteristics of reports that are substantially similar include the following: (a) "at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant pu…
原文 ↗出版商官网 ·- 试验注册 / 报告规范 2. Reporting Guidelines for Specific Study Designs
对于随机对照研究、诊断准确性研究、荟萃分析、观察性研究和非随机研究等特定研究设计,建议作者遵循报告指南,可参考EQUATOR Network和美国国立卫生研究院/国家医学图书馆提供的指南。 模型中文摘要
For the specific study design, such as randomized control studies, studies of diagnostic accuracy, meta-analyses, observational studies, and non-randomized studies, it is recommended that the authors follow the reporting guidelines. A good source of reporting guidelines is the EQUATOR Network (http://www.equator-network.org/home/) and the United States National Institutes of Health/National Librar…
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版国家或地区
- SOUTH KOREA
- 出版周期
- Bimonthly
- 创刊年份
- 2004
- ISSN
- 1738-1843
- 官网最新一期
- Volume 60(2026 年 7 月)
常见问题
关于 Korean Journal of Pathology 的常见问题
Korean Journal of Pathology 的审稿周期多长?
投稿社区反馈的平均审稿速度为6–12 周,平均录用比例反馈为“容易”。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Korean Journal of Pathology 的投稿格式要求是什么?
据期刊作者指南:摘要:≤ 250 词;关键词:3–5 个;参考文献格式:Vancouver 格式;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Korean Journal of Pathology 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 52 位编委中,中国大陆 2 位(约 4%);人数最多的国家是 韩国(28 位)、日本(5 位)、美国(4 位)。统计按编委会页面列出的机构国家计,仅供参考。
Korean Journal of Pathology 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Korean Journal of Pathology 被 DOAJ 收录。
Korean Journal of Pathology 是开放获取期刊吗?版面费多少?
Korean Journal of Pathology 为完全开放获取。APC 约 175 美元。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。